Stellar Biotechnologies, Inc. company info

CIK 1540159
IRS Number 000000000
State of incorporation A1
Business address 332 EAST SCOTT STREET
None
PORT HUENEME
CA
93041
Mail address 332 EAST SCOTT STREET
None
PORT HUENEME
CA
93041

Short summary

Stellar Biotechnologies, Inc. is a California company, with head office located at 332 East Scott Street Port Hueneme, California 93041. In 2018 the company owned a total of 9.15 million USD worth of assets, including 8.14 million USD worth of current assets and 1.01 million USD worth of non-current assets. 2013 was the year when the company amassed the most assets.

Stellar Biotechnologies, Inc. Income Statement

Name [in Millions USD]20112012201320142015201620172018Trends
Cost of Goods and Services Sold 0.060.470.580.820.250.13
Research and development 2.632.022.461.031.731.972.09
Operating Expenses 6.834.396.095.106.185.455.29
Operating Income (Loss) -5.72-4.34-4.91-5.22-5.08
Income Tax Expense (Benefit) 0.000.000.030.040.010.000.00
Net income -5.53-14.50-8.44-2.84-5.03-5.03-5.04

Stellar Biotechnologies, Inc. Balance Sheet

Name [in Millions USD]20112012201320142015201620172018Trends
Cash and cash equivalents 4.151.0014.4410.164.793.655.827.68
Accounts Receivable, Net, Current 0.020.06
Inventories 0.190.570.140.240.24
Property, Plant and Equipment, Gross 0.640.96
Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment 0.390.640.750.921.101.18
Total assets 16.0711.218.509.0212.809.15
Current assets 8.1310.737.738.1211.638.14
Non-current assets 0.370.490.770.901.171.01
Total current liabilities 3.871.780.840.430.410.88
Total liabilities 10.711.782.38
Common Stock, Value, Issued 13.1837.9441.3448.3556.6556.65
Retained Earnings (Accumulated Deficit) -25.18-33.80-39.02-44.17-49.30-53.49

Stellar Biotechnologies, Inc. Cash Flow

Name [in Millions USD]20112012201320142015201620172018Trends
Net income -5.53-14.50-8.44-2.84-5.03-5.03-5.04
Depreciation and amortization 0.080.100.130.160.150.180.19
Depreciation 0.180.19
Amortization of Intangible Assets 0.030.030.03
Depreciation and amortization 0.110.120.160.160.150.18
Accounts receivable -0.030.19-0.120.11-0.07-0.080.04
Inventories 00.52-0.31-0.180.16
Deferred revenue 0.13-0.130.020.09-0.17
Net Cash Provided by (Used in) Operating Activities -4.41-4.51-4.70-4.62
Payments to Acquire Property, Plant, and Equipment 0.080.010.280.270.400.300.38
Net Cash Provided by (Used in) Investing Activities 0.120.561.69-4.47
Net Cash Provided by (Used in) Investing Activities, Continuing Operations -0.08-0.01-0.740.120.56
Stock Issued During Period, Value, Share-based Compensation, Net of Forfeitures 000
Stock Issued During Period, Value, Share-based Compensation, Net of Forfeitures 000
Proceeds from Issuance of Common Stock 8.156.6106.2804.52
Net Cash Provided by (Used in) Financing Activities 0.117.3108.77
Cash and Cash Equivalents, Period Increase (Decrease) -3.156.865.57-4.813.46-2.85-0.35